Chromosome abnormalities in patients treated with 4-hydroperoxycyclophosphamide-purged autologous bone marrow transplantation
- 28 February 1993
- journal article
- Published by Elsevier in Cancer Genetics and Cytogenetics
- Vol. 65 (2) , 135-140
- https://doi.org/10.1016/0165-4608(93)90222-8
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Allogeneic bone marrow transplantation for patients with high-risk acute lymphoblastic leukemia.Journal of Clinical Oncology, 1990
- Efficacy of ex vivo purging for autologous bone marrow transplantation in the treatment of acute nonlymphoblastic leukemiaBlood, 1989
- Tetraploidy (92,XXYY) in an acute nonlymphocytic leukemia (M1) patient following autologous bone marrow transplantationCancer Genetics and Cytogenetics, 1988
- Autologous Bone Marrow Transplantation in Patients with Acute Nonlymphocytic Leukemia, Using ex Vivo Marrow Treatment with 4-HydroperoxycyclophosphamideNew England Journal of Medicine, 1986
- Cytogenetic effects of cyclophosphamide on human lymphocytes in vivo and in vitroMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1986
- The 5q− anomalyCancer Genetics and Cytogenetics, 1985
- CHROMOSOME ABNORMALITIES AFTER AUTOLOGOUS BONE MARROW TRANSPLANTATION WITH MARROW TREATED BY CYCLOPHOSPHAMIDE DERIVATIVESThe Lancet, 1985